BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31872382)

  • 1. Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells.
    Xu S; Wu X; Tao Z; Li H; Fan C; Chen S; Guo J; Ning Y; Hu X
    Genes Genomics; 2020 Mar; 42(3):299-307. PubMed ID: 31872382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers.
    Xu B; Tang G; Xiao C; Wang L; Yang Q; Sun Y
    Int J Clin Exp Pathol; 2014; 7(6):2883-93. PubMed ID: 25031707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1.
    Zhang Y; Chen B; Xu N; Xu P; Lin W; Liu C; Huang P
    Int J Nanomedicine; 2021; 16():315-327. PubMed ID: 33469288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.
    He M; Liu Y; Deng X; Qi S; Sun X; Liu G; Liu Y; Liu Y; Zhao M
    Prostate; 2013 Jul; 73(10):1048-56. PubMed ID: 23389960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
    Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
    Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.
    Wolff DW; Xie Y; Deng C; Gatalica Z; Yang M; Wang B; Wang J; Lin MF; Abel PW; Tu Y
    Int J Cancer; 2012 Apr; 130(7):1521-31. PubMed ID: 21500190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
    Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
    Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.
    Ito S; Ueda T; Ueno A; Nakagawa H; Taniguchi H; Hongo F; Kamoi K; Okihara K; Kawauchi A; Miki T
    FEBS J; 2014 Oct; 281(19):4506-18. PubMed ID: 25132193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1.
    Xu B; Huang Y; Niu X; Tao T; Jiang L; Tong N; Chen S; Liu N; Zhu W; Chen M
    Prostate; 2015 Dec; 75(16):1896-903. PubMed ID: 26306811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
    Majumder S; Liu Y; Ford OH; Mohler JL; Whang YE
    Prostate; 2006 Sep; 66(12):1292-301. PubMed ID: 16705743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway.
    Divakar S; Saravanan K; Karthikeyan P; Elancheran R; Kabilan S; Balasubramanian KK; Devi R; Kotoky J; Ramanathan M
    Chem Biol Interact; 2017 Sep; 275():22-34. PubMed ID: 28757136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene microarray assessment of multiple genes and signal pathways involved in androgen-dependent prostate cancer becoming androgen independent.
    Liu JB; Dai CM; Su XY; Cao L; Qin R; Kong QB
    Asian Pac J Cancer Prev; 2014; 15(22):9791-5. PubMed ID: 25520106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer].
    Zhang X; Tang Z; Qi L; Chen H; Luo Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGF/γ-IFN inhibits androgen-independent prostate cancer and reverses androgen receptor function through downregulation of FGFR2 and decrease in cancer stem cells.
    Chen W; Wang GM; Guo JM; Sun LA; Wang H
    Stem Cells Dev; 2012 Dec; 21(18):3372-80. PubMed ID: 22731611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].
    Li TQ; Feng CQ; Zou YG; Shi R; Liang S; Mao XM
    Zhonghua Nan Ke Xue; 2009 Dec; 15(12):1102-7. PubMed ID: 20180422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.
    Sharad S; Ravindranath L; Haffner MC; Li H; Yan W; Sesterhenn IA; Chen Y; Ali A; Srinivasan A; McLeod DG; Yegnasubramanian S; Srivastava S; Dobi A; Petrovics G
    Epigenetics; 2014 Jun; 9(6):918-27. PubMed ID: 24694733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.